Non-invasive, Real-time Anesthetic Drug-monitoring System

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02776020

Acronym

ADM

Enrollment

Registered

2016-05-18

Start date

2016-06-30

Completion date

2017-02-28

Last updated

2016-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Brief summary

The aim of this study is to determine efficacy of the CorrecDose device to continuously and non-invasively follow the changes in propofol concentrations in the participants' blood.

Interventions

DEVICECorrecDose Infrared Monitor

The monitor is attached to patient's wrist and ear in order to measure changes in propofol concentrations in blood

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Women who have signed Informed consent form * Women undergoing Trans vaginal ovum retrieval (TVOR) for invitro fertilization (IVF) and will be sedated with propofol administered intravenos (IV)

Exclusion criteria

* Women with background diseases * Women with chronic use of drug and medication * Women with peripheral blood vessels problems * Women with high blood pressure * Women with body mass index (BMI) score over 35 or less than 18

Design outcomes

Primary

Measure	Time frame	Description
Changes in Propofol Blood Levels	Half hour	Graphic display on monitor of real-time changes

Contacts

Primary ContactPhilippe Abecassis, MD

p_abecassis@rambam.health.gov.il+972502061058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026